Sanofi sells out of Tamiflu in one day
It took less than a day for Sanofi Pasteur to sell the 50 million doses of Tamiflu it plans to make for the 2006-2007 flu season. Sanofi has been inundated with orders for Tamiflu, which may help fight the deadly H5N1 virus that has killed dozens of people in Turkey and Asia. Fears have grown that the virus, which spreads from birds to people, may mutate into a disease that can spread from person to person.
- read this report from the Pocono Record
PLUS: The U.S. government has ordered an extra $50 million of experimental bird flu vaccine from Sanofi-Aventis to stockpile against a potential flu pandemic. That's on top of the $100 million order made by the U.S. in September. Report
ALSO: Local health authorities say that very little real planning is underway in the U.S. for a pandemic and few new funds are being made available to change that anytime soon. Article
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
- Forecast Model: Antidyslipidemics - Genericization and negative trial data drive market shrinkage
